A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer

• Harsh B. Pathak ,

  * E-mail: hpathak@kumc.edu

  Affiliations Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America, University of Kansas Cancer Center, Kansas City, Kansas, United States of America

  ⨯
• Yan Zhou,

  Affiliation Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Geetika Sethi,

  Current address: Institute for Systems Biology, Seattle, Washington, United States of America

  Affiliation Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Jeff Hirst,

  Affiliation Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  ⨯
• Russell J. Schilder,

  Affiliation Department of Gynecologic Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

  ⨯
• Erica A. Golemis,

  Affiliation Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Andrew K. Godwin

  Affiliations Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America, University of Kansas Cancer Center, Kansas City, Kansas, United States of America

  ⨯